Published

Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Digestive and Liver Disease
Date: 2025-02-01
Source: OpenAlex
DOI: 10.1016/j.dld.2025.01.134
PubMed: Unavailable

Authors

A. Signor Martina Colognesi Daniela Gabbia Ilaria Zanotto Y. Frion-Herrera Stefano Comai Andrea Mattarei Gianfranco Pasut Franco Folli M. Pappagallo Paolo Manfredi S. De Martin

Watch author

Derived topics and classifications

psilocybin Pharmacology Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes2025-02-01

Related papers

Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-07-01 Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07 Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2022-01-01 P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-12-01 Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate PathwayDOAJ (DOAJ: Directory of Open Access Journals) · 2018-03-01 EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic actionEuropean Psychiatry · 2013-12-31 Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and NeurogenesisDigital Commons - University of South Florida (University of South Florida) · 2007-12-31 Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosisPharmacopsychiatry · 2005-09-01